IN2015DN00085A - - Google Patents

Download PDF

Info

Publication number
IN2015DN00085A
IN2015DN00085A IN85DEN2015A IN2015DN00085A IN 2015DN00085 A IN2015DN00085 A IN 2015DN00085A IN 85DEN2015 A IN85DEN2015 A IN 85DEN2015A IN 2015DN00085 A IN2015DN00085 A IN 2015DN00085A
Authority
IN
India
Prior art keywords
compounds
preparation
general formula
methods
well
Prior art date
Application number
Other languages
English (en)
Inventor
Volker Schulze
Franz Josef Mais
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of IN2015DN00085A publication Critical patent/IN2015DN00085A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN85DEN2015 2012-07-10 2013-07-03 IN2015DN00085A (Direct)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP12175640 2012-07-10
EP12185590 2012-09-24
EP13170585 2013-06-05
PCT/EP2013/064017 WO2014009219A1 (en) 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines

Publications (1)

Publication Number Publication Date
IN2015DN00085A true IN2015DN00085A (Direct) 2015-05-29

Family

ID=48793197

Family Applications (1)

Application Number Title Priority Date Filing Date
IN85DEN2015 IN2015DN00085A (Direct) 2012-07-10 2013-07-03

Country Status (24)

Country Link
US (1) US9388177B2 (Direct)
EP (1) EP2872506A1 (Direct)
JP (1) JP6238979B2 (Direct)
KR (1) KR20150040845A (Direct)
CN (1) CN104603136B (Direct)
AP (1) AP3778A (Direct)
AU (1) AU2013289381A1 (Direct)
BR (1) BR112015000308A2 (Direct)
CA (1) CA2878481A1 (Direct)
CL (1) CL2015000038A1 (Direct)
CO (1) CO7160002A2 (Direct)
CR (1) CR20150006A (Direct)
DO (1) DOP2015000007A (Direct)
EA (1) EA027544B1 (Direct)
HK (1) HK1206731A1 (Direct)
IL (1) IL236265A (Direct)
IN (1) IN2015DN00085A (Direct)
MX (1) MX2015000348A (Direct)
NZ (1) NZ703020A (Direct)
PE (1) PE20150354A1 (Direct)
PH (1) PH12015500061A1 (Direct)
SG (1) SG11201408419QA (Direct)
TN (1) TN2015000008A1 (Direct)
WO (1) WO2014009219A1 (Direct)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160264568A1 (en) * 2013-06-07 2016-09-15 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines having activity as mps-1 inhibitors
MX2015017120A (es) 2013-06-11 2016-10-05 Bayer Pharma AG Combinaciones para el tratamiento de cancer que comprende un inhibidor de la quinasa mps-1 y un inhibidor de la mitosis.
CA2914745A1 (en) * 2013-06-11 2014-12-18 Bayer Pharma Aktiengesellschaft Prodrug derivatives of substituted triazolopyridines
WO2016166255A1 (en) 2015-04-17 2016-10-20 Netherlands Translational Research Center B.V. Prognostic biomarkers for ttk inhibitor chemotherapy
TW201800408A (zh) 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1438973A4 (en) * 2001-10-05 2005-07-13 Ono Pharmaceutical Co MEANS FOR THE TREATMENT OF STRESS-RELATED DISEASES WITH MITOCHONDRIENE BENZODIAZEPINE RECEPTOR ANTAGONISTS
WO2005110410A2 (en) * 2004-05-14 2005-11-24 Abbott Laboratories Kinase inhibitors as therapeutic agents
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
MX2007004179A (es) * 2004-10-07 2007-06-07 Warner Lambert Co Derivados de triazolpiridina como agentes antibacterianos.
US20060194823A1 (en) * 2004-12-22 2006-08-31 Georg Kettschau Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
US7557104B2 (en) * 2006-06-06 2009-07-07 Schering Corporation Imidazopyrazines as protein kinase inhibitors
EP1870416A1 (en) * 2006-06-21 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Sulphonamido-macrocycles as tie2 inhibitors
JP5336375B2 (ja) 2006-08-30 2013-11-06 セルゾーム リミテッド キナーゼ阻害剤としてのトリアゾール誘導体
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
CN101801966A (zh) 2007-07-18 2010-08-11 诺瓦提斯公司 双环杂芳基化合物和它们作为激酶抑制剂的用途
NZ584138A (en) 2007-08-23 2011-10-28 Astrazeneca Ab 2-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disorders
EA201070328A1 (ru) 2007-08-31 2010-08-30 Мерк Сероно С.А. Соединения триазолопиридина и их применение в качестве ингибиторов ask
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
WO2009137322A2 (en) * 2008-05-05 2009-11-12 The Trustees Of The University Of Pennsylvania Processes for the preparation of biphenyl compounds
EP2303890A4 (en) * 2008-06-19 2012-04-11 Progenics Pharm Inc INHIBITORS OF PHOSPHATIDYLINOSITE-3-KINASE
US20120041195A1 (en) 2009-02-13 2012-02-16 Fovea Pharmaceuticals Heterocyclic compounds
ES2547328T3 (es) 2009-04-29 2015-10-05 Bayer Intellectual Property Gmbh Imidazoquinoxalinas sustituidas
AU2010254806C1 (en) * 2009-06-05 2016-07-07 Cephalon, Inc. Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
CN102596932A (zh) 2009-09-04 2012-07-18 拜耳医药股份有限公司 作为酪氨酸苏氨酸激酶抑制剂的取代氨基喹喔啉
EP2343294A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
EP2343295A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridine derivates
EP2343297A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
WO2012044567A2 (en) * 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Imidazole derivatives
PL2699575T3 (pl) 2011-04-21 2015-08-31 Bayer Ip Gmbh Triazolopirydyny
WO2012160029A1 (en) * 2011-05-23 2012-11-29 Bayer Intellectual Property Gmbh Substituted triazolopyridines
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk

Also Published As

Publication number Publication date
HK1206731A1 (en) 2016-01-15
US9388177B2 (en) 2016-07-12
US20150148542A1 (en) 2015-05-28
IL236265A (en) 2017-07-31
AP2014008177A0 (en) 2014-12-31
AU2013289381A1 (en) 2015-01-22
PH12015500061A1 (en) 2015-03-02
NZ703020A (en) 2017-08-25
CN104603136B (zh) 2017-06-27
WO2014009219A1 (en) 2014-01-16
CO7160002A2 (es) 2015-01-15
IL236265A0 (en) 2015-02-26
BR112015000308A2 (pt) 2017-06-27
SG11201408419QA (en) 2015-01-29
JP6238979B2 (ja) 2017-11-29
EA201590116A1 (ru) 2015-07-30
EP2872506A1 (en) 2015-05-20
DOP2015000007A (es) 2015-02-15
CN104603136A (zh) 2015-05-06
KR20150040845A (ko) 2015-04-15
EA027544B1 (ru) 2017-08-31
MX2015000348A (es) 2015-04-14
CR20150006A (es) 2015-02-16
JP2015523372A (ja) 2015-08-13
AP3778A (en) 2016-08-31
PE20150354A1 (es) 2015-03-21
TN2015000008A1 (en) 2016-06-29
CL2015000038A1 (es) 2015-03-13
CA2878481A1 (en) 2014-01-16

Similar Documents

Publication Publication Date Title
NZ743274A (en) Substituted tricyclic compounds as fgfr inhibitors
ZA201500316B (en) Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof
AU2012213775A8 (en) 7-azaindole derivatives
MD20150091A2 (ro) Compuşi antivirali
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
IL235944A0 (en) β-lactamase inhibitor compounds, preparations containing them, methods for their preparation and their uses
MX352881B (es) Metodos y compuestos utiles en la sintesis de antagonistas del receptor de orexina 2.
IN2014MN02598A (Direct)
IN2014DN06104A (Direct)
EA201590887A1 (ru) Композиция
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
MY173521A (en) Trpv4 antagonists
UA114655C2 (uk) Піридин-2-аміди, придатні як агоністи канабіноїдного рецептора 2
NZ607149A (en) Galacto-oligosaccharide-containing composition and a method of producing it
MX2014005510A (es) Nuevas composiciones, produccion de las mismas y uso de las mismas para la produccion de poliamidas coladas.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
PH12015501175A1 (en) Substituted pyridopyrazines as syk inhibitors
GEP201706626B (en) Synthesis of (s)-nifuratel
IN2015DN00085A (Direct)
MX347541B (es) Analogos de acido sialico.
GB201107985D0 (en) Process
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
MX367773B (es) Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
AU2012248013B2 (en) Intermediate for synthesizing caspofungin and preparation method therefor